JP Morgan Chase’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Buy
42,977
+7,501
+21% +$290K ﹤0.01% 4285
2026
Q1
$1.32M Buy
35,476
+15,203
+75% +$497K ﹤0.01% 4403
2025
Q4
$610K Buy
20,273
+12,374
+157% +$350K ﹤0.01% 4900
2025
Q3
$207K Buy
7,899
+1,872
+31% +$44.6K ﹤0.01% 5491
2025
Q2
$128K Buy
6,027
+1,956
+48% +$44.1K ﹤0.01% 5488
2025
Q1
$86.5K Buy
4,071
+286
+8% +$5.87K ﹤0.01% 5644
2024
Q4
$76.7K Buy
+3,785
New +$78.2K ﹤0.01% 5855

Other funds holding GRDN

JP Morgan Chase's GRDN Position: Q2 2026 in Review

JP Morgan Chase increased its Guardian Pharmacy Services (GRDN) stake by 21% in Q2 2026, buying an estimated $290K and bringing the position to 42,977 shares worth $1.74M. The position accounts for ﹤0.01% of the portfolio, ranked #4285.

JP Morgan Chase first reported a position in GRDN in Q4 2024 and has held it in 7 quarters since. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • JP Morgan Chase held 42,977 shares of Guardian Pharmacy Services worth $1.74M as of Q2 2026.
  • JP Morgan Chase bought 7,501 Guardian Pharmacy Services shares in Q2 2026, an estimated $290K.
  • Guardian Pharmacy Services made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4285 holding.
  • JP Morgan Chase first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 7 quarters since.
  • 190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.